SecBot SecBot
PRESS-RELEASE ·Filed Jul 7, 2026

RMD

Resmed, Inc.
NEUTRAL
Impact 4/10
Horizonmonths Processed4mo ago WireGlobeNewswire
Press release · M&A
Actionable Insight • Neutral

The divestiture streamlines Resmed's portfolio but provides no deal value or financial details. Monitor Resmed's Q4 FY2026 regulatory filings for sale price and any gain/loss recognition. The stock may see modest pressure if the sale price implies a small or distressed valuation; absence of price disclosure is a slight negative signal.

DirectionNeutral
Confidencemedium
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$205.84
T+0 close · Jul 7, 2026 · via day close
Latest settled
+7.44%
T+60 · $221.15
Vs SPY
+4.94%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 8 $205.84entry
  2. T+1 · 4mo ago +1.27%α +0.42% · $208.45
  3. T+5 · 4mo ago −6.23%α −7.10% · $193.01
  4. T+20 · 3mo ago +8.84%α +5.56% · $224.03
  5. T+60 · 7w ago +7.44%α +4.94% · $221.15
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Resmed has agreed to sell its long-term care software business MatrixCare to Frazier Healthcare Partners. The move focuses Resmed on its core sleep, breathing, and home-based healthcare strategy but the press release does not disclose the sale price, implying it may be small relative to Resmed's $31.7B market cap. The transaction is expected to close in Q1 FY2027, subject to regulatory approvals.

Key Facts

  • Resmed entered a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners.
  • MatrixCare serves over 15,000 providers in skilled nursing, senior living, long-term care, and home health/hospice.
  • The transaction is expected to close in Q1 of fiscal year 2027 (approximately October-December 2026).
  • The sale price is not disclosed in the press release.
  • The divestiture excludes Resmed's other software businesses Brightree (US) and MEDIFOX DAN (Germany).
  • Frazier Healthcare Partners is a private equity firm that has raised over $11B and invested in more than 200 healthcare companies.

Financial Impact

Sale price undisclosed; MatrixCare's revenue contribution is not stated, so the financial magnitude relative to Resmed's $31.7B market cap cannot be determined.

revenue

Risk Factors

  • Undisclosed sale price may be small relative to market cap or imply a discounted valuation.
  • Regulatory approvals could delay or block the transaction.
  • MatrixCare's departure removes a diversified revenue stream in the long-term care software market.

Market Snapshot

Exchange
OTC
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
60% bullish (25 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3323651

Track record

19 reports on RMD

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +28.97% at T+60 after the Jun 1, 2026 report. 6 of 6 went positive at some point.

Filters
  1. Nov 9, 20267d ago 144 Neutral 2/10 Entry $234.11 Now $238.19 +1.74% settles Dec 9
  2. Oct 29, 202618d ago 8-K Bullish 6/10 No price data
  3. Oct 29, 202618d ago Press Release Bullish 6/10 Entry $229.94 Now $238.19 +3.59% settles Nov 30
  4. Oct 16, 20264w ago Institutional Cluster Bearish 4/10 Entry $238.88 to $238.19 Now $238.19 +0.29% ▲ +0.29% −3.17% vs SPY
  5. Oct 7, 20265w ago 144 Neutral 3/10 Entry $226.73 to $240.51 Now $238.19 +5.05% ▲ +6.08% +11.37% vs SPY
  6. Oct 1, 20266w ago DEFA14A Neutral 2/10 Entry $218.89 to $229.94 Now $238.19 +8.82% ▲ +5.05% +6.86% vs SPY
  7. Oct 1, 20266w ago DEF 14A Neutral 4/10 Entry $218.89 to $252.83 Now $238.19 +8.82% ▲ +15.51% +17.31% vs SPY
  8. Oct 1, 20266w ago Press Release Neutral 1/10 Entry $218.89 Now $238.19 +8.82% No price data
  9. Sep 10, 20269w ago Insider Cluster Neutral 4/10 Entry $219.58 to $226.73 Now $238.19 +8.48% ▲ +3.26% +1.13% vs SPY
  10. Aug 11, 202613w ago Insider Cluster Neutral 2/10 Entry $224.84 to $219.95 Now $238.19 +5.94% ▼ −2.17% −1.12% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens Wed (11h 30m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 7, 2026